The partnership with Hurts is a natural extension of the company’s 20-year relationship with the Philadelphia…
Continue ReadingCategoría: Business Wire
Categoría agregada por el Plugin WPeMatico
BankUnited, Inc. Reports Second Quarter 2024 Results
MIAMI LAKES, Fla.–(BUSINESS WIRE)–BankUnited, Inc. (the “Company”) (NYSE: BKU) today announced financial results for the quarter…
Continue Reading
Flux Power Receives OEM-Approval for New L-Series L36-630|840 Ah Battery Packs for Class 1 3-Wheel Counterbalance Forklifts
L36 Addresses Customer Demand for UL Listed Heavy-Duty Battery Packs Optimized to Deliver Peak Performance Featuring…
Continue ReadingPolitan Comments on Masimo’s Latest Entrenchment Maneuvers
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any…
Continue Reading
Corporación América Airports S.A. Reports June 2024 Passenger Traffic
Total passenger traffic down 8.9% YoY, or 6.7% YoY ex-Natal International passenger traffic up 9.4% YoY…
Continue Reading
Paradigm BioDevices Launches VisiCORE ™ – The Clear Choice in Bone Graft Harvesting
CHARLESTON, S.C.–(BUSINESS WIRE)–Paradigm BioDevices, Inc. announces the launch of VisiCORE, a new bone graft harvesting system…
Continue ReadingEnfusion Announces Date of Second Quarter 2024 Results
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of…
Continue Reading
Beyond, Inc. Scheduled to Release Second Quarter 2024 Financial Results
MIDVALE, Utah–(BUSINESS WIRE)–Beyond, Inc. (NYSE:BYON), owner of Overstock, Bed Bath & Beyond, Zulily, and other online…
Continue ReadingAdaptHealth Corp. Announces Second Quarter 2024 Earnings Release Date and Conference Call
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing…
Continue Reading
Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024
– Late-Breaking Full Results from HIV Prevention Research of Twice-Yearly Injectable Lenacapavir – – Progress and…
Continue Reading